Click for best price
PET Radiopharmaceuticals Market Size, Share 2022
This report contains market size and forecasts of PET Radiopharmaceuticals in global, including the following market information:
Global PET Radiopharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global PET Radiopharmaceuticals Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five PET Radiopharmaceuticals companies in 2021 (%)
The global PET Radiopharmaceuticals market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
F-18 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PET Radiopharmaceuticals include Cardinal Health Inc. (U.S.), Mallinckrodt plc (Ireland), GE Healthcare (U.K.), Lantheus Medical Imaging, Inc. (U.S.), Bayer AG (Germany), Bracco Imaging S.p.A (Italy), Eczacibasi-Monrol Nuclear Products (Turkey), Nordion, Inc. (Canada) and Advanced Accelerator Applications S.A. (France) and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the PET Radiopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PET Radiopharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global PET Radiopharmaceuticals Market Segment Percentages, by Type, 2021 (%)
F-18
Ru-82
Others
Global PET Radiopharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global PET Radiopharmaceuticals Market Segment Percentages, by Application, 2021 (%)
Oncology
Cardiology
Neurology
Others
Global PET Radiopharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global PET Radiopharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PET Radiopharmaceuticals revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies PET Radiopharmaceuticals revenues share in global market, 2021 (%)
Key companies PET Radiopharmaceuticals sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies PET Radiopharmaceuticals sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)
| Report Attributes |
Report Details |
| Report Title |
PET Radiopharmaceuticals Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
74 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 PET Radiopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PET Radiopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global PET Radiopharmaceuticals Overall Market Size
2.1 Global PET Radiopharmaceuticals Market Size: 2021 VS 2028
2.2 Global PET Radiopharmaceuticals Revenue, Prospects & Forecasts: 2017-2028
2.3 Global PET Radiopharmaceuticals Sales: 2017-2028
3 Company Landscape
3.1 Top PET Radiopharmaceuticals Players in Global Market
3.2 Top Global PET Radiopharmaceuticals Companies Ranked by Revenue
3.3 Global PET Radiopharmaceuticals Revenue by Companies
3.4 Global PET Radiopharmaceuticals Sales by Companies
3.5 Global PET Radiopharmaceuticals Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 PET Radiopharmaceuticals Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers PET Radiopharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 PET Radiopharmaceuticals Players in Global Market
3.8.1 List of Global Tier 1 PET Radiopharmaceuticals Companies
3.8.2 List of Global Tier 2 and Tier 3 PET Radiopharmaceuticals Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global PET Radiopharmaceuticals Market Size Markets, 2021 & 2028
4.1.2 F-18
4.1.3 Ru-82
4.1.4 Others
4.2 By Type - Global PET Radiopharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global PET Radiopharmaceuticals Revenue, 2017-2022
4.2.2 By Type - Global PET Radiopharmaceuticals Revenue, 2023-2028
4.2.3 By Type - Global PET Radiopharmaceuticals Revenue Market Share, 2017-2028
4.3 By Type - Global PET Radiopharmaceuticals Sales & Forecasts
4.3.1 By Type - Global PET Radiopharmaceuticals Sales, 2017-2022
4.3.2 By Type - Global PET Radiopharmaceuticals Sales, 2023-2028
4.3.3 By Type - Global PET Radiopharmaceuticals Sales Market Share, 2017-2028
4.4 By Type - Global PET Radiopharmaceuticals Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global PET Radiopharmaceuticals Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 Neurology
5.1.5 Others
5.2 By Application - Global PET Radiopharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global PET Radiopharmaceuticals Revenue, 2017-2022
5.2.2 By Application - Global PET Radiopharmaceuticals Revenue, 2023-2028
5.2.3 By Application - Global PET Radiopharmaceuticals Revenue Market Share, 2017-2028
5.3 By Application - Global PET Radiopharmaceuticals Sales & Forecasts
5.3.1 By Application - Global PET Radiopharmaceuticals Sales, 2017-2022
5.3.2 By Application - Global PET Radiopharmaceuticals Sales, 2023-2028
5.3.3 By Application - Global PET Radiopharmaceuticals Sales Market Share, 2017-2028
5.4 By Application - Global PET Radiopharmaceuticals Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global PET Radiopharmaceuticals Market Size, 2021 & 2028
6.2 By Region - Global PET Radiopharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global PET Radiopharmaceuticals Revenue, 2017-2022
6.2.2 By Region - Global PET Radiopharmaceuticals Revenue, 2023-2028
6.2.3 By Region - Global PET Radiopharmaceuticals Revenue Market Share, 2017-2028
6.3 By Region - Global PET Radiopharmaceuticals Sales & Forecasts
6.3.1 By Region - Global PET Radiopharmaceuticals Sales, 2017-2022
6.3.2 By Region - Global PET Radiopharmaceuticals Sales, 2023-2028
6.3.3 By Region - Global PET Radiopharmaceuticals Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America PET Radiopharmaceuticals Revenue, 2017-2028
6.4.2 By Country - North America PET Radiopharmaceuticals Sales, 2017-2028
6.4.3 US PET Radiopharmaceuticals Market Size, 2017-2028
6.4.4 Canada PET Radiopharmaceuticals Market Size, 2017-2028
6.4.5 Mexico PET Radiopharmaceuticals Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe PET Radiopharmaceuticals Revenue, 2017-2028
6.5.2 By Country - Europe PET Radiopharmaceuticals Sales, 2017-2028
6.5.3 Germany PET Radiopharmaceuticals Market Size, 2017-2028
6.5.4 France PET Radiopharmaceuticals Market Size, 2017-2028
6.5.5 U.K. PET Radiopharmaceuticals Market Size, 2017-2028
6.5.6 Italy PET Radiopharmaceuticals Market Size, 2017-2028
6.5.7 Russia PET Radiopharmaceuticals Market Size, 2017-2028
6.5.8 Nordic Countries PET Radiopharmaceuticals Market Size, 2017-2028
6.5.9 Benelux PET Radiopharmaceuticals Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia PET Radiopharmaceuticals Revenue, 2017-2028
6.6.2 By Region - Asia PET Radiopharmaceuticals Sales, 2017-2028
6.6.3 China PET Radiopharmaceuticals Market Size, 2017-2028
6.6.4 Japan PET Radiopharmaceuticals Market Size, 2017-2028
6.6.5 South Korea PET Radiopharmaceuticals Market Size, 2017-2028
6.6.6 Southeast Asia PET Radiopharmaceuticals Market Size, 2017-2028
6.6.7 India PET Radiopharmaceuticals Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America PET Radiopharmaceuticals Revenue, 2017-2028
6.7.2 By Country - South America PET Radiopharmaceuticals Sales, 2017-2028
6.7.3 Brazil PET Radiopharmaceuticals Market Size, 2017-2028
6.7.4 Argentina PET Radiopharmaceuticals Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa PET Radiopharmaceuticals Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa PET Radiopharmaceuticals Sales, 2017-2028
6.8.3 Turkey PET Radiopharmaceuticals Market Size, 2017-2028
6.8.4 Israel PET Radiopharmaceuticals Market Size, 2017-2028
6.8.5 Saudi Arabia PET Radiopharmaceuticals Market Size, 2017-2028
6.8.6 UAE PET Radiopharmaceuticals Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Cardinal Health Inc. (U.S.)
7.1.1 Cardinal Health Inc. (U.S.) Corporate Summary
7.1.2 Cardinal Health Inc. (U.S.) Business Overview
7.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Major Product Offerings
7.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.1.5 Cardinal Health Inc. (U.S.) Key News
7.2 Mallinckrodt plc (Ireland)
7.2.1 Mallinckrodt plc (Ireland) Corporate Summary
7.2.2 Mallinckrodt plc (Ireland) Business Overview
7.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Major Product Offerings
7.2.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.2.5 Mallinckrodt plc (Ireland) Key News
7.3 GE Healthcare (U.K.)
7.3.1 GE Healthcare (U.K.) Corporate Summary
7.3.2 GE Healthcare (U.K.) Business Overview
7.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Major Product Offerings
7.3.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.3.5 GE Healthcare (U.K.) Key News
7.4 Lantheus Medical Imaging, Inc. (U.S.)
7.4.1 Lantheus Medical Imaging, Inc. (U.S.) Corporate Summary
7.4.2 Lantheus Medical Imaging, Inc. (U.S.) Business Overview
7.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Major Product Offerings
7.4.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.4.5 Lantheus Medical Imaging, Inc. (U.S.) Key News
7.5 Bayer AG (Germany)
7.5.1 Bayer AG (Germany) Corporate Summary
7.5.2 Bayer AG (Germany) Business Overview
7.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Major Product Offerings
7.5.4 Bayer AG (Germany) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.5.5 Bayer AG (Germany) Key News
7.6 Bracco Imaging S.p.A (Italy)
7.6.1 Bracco Imaging S.p.A (Italy) Corporate Summary
7.6.2 Bracco Imaging S.p.A (Italy) Business Overview
7.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Major Product Offerings
7.6.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.6.5 Bracco Imaging S.p.A (Italy) Key News
7.7 Eczacibasi-Monrol Nuclear Products (Turkey)
7.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Corporate Summary
7.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Business Overview
7.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Major Product Offerings
7.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Key News
7.8 Nordion, Inc. (Canada)
7.8.1 Nordion, Inc. (Canada) Corporate Summary
7.8.2 Nordion, Inc. (Canada) Business Overview
7.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Major Product Offerings
7.8.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.8.5 Nordion, Inc. (Canada) Key News
7.9 Advanced Accelerator Applications S.A. (France)
7.9.1 Advanced Accelerator Applications S.A. (France) Corporate Summary
7.9.2 Advanced Accelerator Applications S.A. (France) Business Overview
7.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Major Product Offerings
7.9.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.9.5 Advanced Accelerator Applications S.A. (France) Key News
7.10 IBA Molecular Imaging (Belgium)
7.10.1 IBA Molecular Imaging (Belgium) Corporate Summary
7.10.2 IBA Molecular Imaging (Belgium) Business Overview
7.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Major Product Offerings
7.10.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.10.5 IBA Molecular Imaging (Belgium) Key News
8 Global PET Radiopharmaceuticals Production Capacity, Analysis
8.1 Global PET Radiopharmaceuticals Production Capacity, 2017-2028
8.2 PET Radiopharmaceuticals Production Capacity of Key Manufacturers in Global Market
8.3 Global PET Radiopharmaceuticals Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PET Radiopharmaceuticals Supply Chain Analysis
10.1 PET Radiopharmaceuticals Industry Value Chain
10.2 PET Radiopharmaceuticals Upstream Market
10.3 PET Radiopharmaceuticals Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 PET Radiopharmaceuticals Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of PET Radiopharmaceuticals in Global Market
Table 2. Top PET Radiopharmaceuticals Players in Global Market, Ranking by Revenue (2021)
Table 3. Global PET Radiopharmaceuticals Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global PET Radiopharmaceuticals Revenue Share by Companies, 2017-2022
Table 5. Global PET Radiopharmaceuticals Sales by Companies, (K Pcs), 2017-2022
Table 6. Global PET Radiopharmaceuticals Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers PET Radiopharmaceuticals Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers PET Radiopharmaceuticals Product Type
Table 9. List of Global Tier 1 PET Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 PET Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global PET Radiopharmaceuticals Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global PET Radiopharmaceuticals Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global PET Radiopharmaceuticals Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global PET Radiopharmaceuticals Sales (K Pcs), 2017-2022
Table 15. By Type - Global PET Radiopharmaceuticals Sales (K Pcs), 2023-2028
Table 16. By Application ? Global PET Radiopharmaceuticals Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global PET Radiopharmaceuticals Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global PET Radiopharmaceuticals Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global PET Radiopharmaceuticals Sales (K Pcs), 2017-2022
Table 20. By Application - Global PET Radiopharmaceuticals Sales (K Pcs), 2023-2028
Table 21. By Region ? Global PET Radiopharmaceuticals Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global PET Radiopharmaceuticals Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global PET Radiopharmaceuticals Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global PET Radiopharmaceuticals Sales (K Pcs), 2017-2022
Table 25. By Region - Global PET Radiopharmaceuticals Sales (K Pcs), 2023-2028
Table 26. By Country - North America PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America PET Radiopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America PET Radiopharmaceuticals Sales, (K Pcs), 2017-2022
Table 29. By Country - North America PET Radiopharmaceuticals Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe PET Radiopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe PET Radiopharmaceuticals Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe PET Radiopharmaceuticals Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia PET Radiopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia PET Radiopharmaceuticals Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia PET Radiopharmaceuticals Sales, (K Pcs), 2023-2028
Table 38. By Country - South America PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America PET Radiopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America PET Radiopharmaceuticals Sales, (K Pcs), 2017-2022
Table 41. By Country - South America PET Radiopharmaceuticals Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa PET Radiopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa PET Radiopharmaceuticals Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa PET Radiopharmaceuticals Sales, (K Pcs), 2023-2028
Table 46. Cardinal Health Inc. (U.S.) Corporate Summary
Table 47. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Offerings
Table 48. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Mallinckrodt plc (Ireland) Corporate Summary
Table 50. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Offerings
Table 51. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. GE Healthcare (U.K.) Corporate Summary
Table 53. GE Healthcare (U.K.) PET Radiopharmaceuticals Product Offerings
Table 54. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Lantheus Medical Imaging, Inc. (U.S.) Corporate Summary
Table 56. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Offerings
Table 57. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Bayer AG (Germany) Corporate Summary
Table 59. Bayer AG (Germany) PET Radiopharmaceuticals Product Offerings
Table 60. Bayer AG (Germany) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Bracco Imaging S.p.A (Italy) Corporate Summary
Table 62. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Offerings
Table 63. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Eczacibasi-Monrol Nuclear Products (Turkey) Corporate Summary
Table 65. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Offerings
Table 66. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Nordion, Inc. (Canada) Corporate Summary
Table 68. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Offerings
Table 69. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Advanced Accelerator Applications S.A. (France) Corporate Summary
Table 71. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Offerings
Table 72. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. IBA Molecular Imaging (Belgium) Corporate Summary
Table 74. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Offerings
Table 75. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. PET Radiopharmaceuticals Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 77. Global PET Radiopharmaceuticals Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global PET Radiopharmaceuticals Production by Region, 2017-2022 (K Pcs)
Table 79. Global PET Radiopharmaceuticals Production by Region, 2023-2028 (K Pcs)
Table 80. PET Radiopharmaceuticals Market Opportunities & Trends in Global Market
Table 81. PET Radiopharmaceuticals Market Drivers in Global Market
Table 82. PET Radiopharmaceuticals Market Restraints in Global Market
Table 83. PET Radiopharmaceuticals Raw Materials
Table 84. PET Radiopharmaceuticals Raw Materials Suppliers in Global Market
Table 85. Typical PET Radiopharmaceuticals Downstream
Table 86. PET Radiopharmaceuticals Downstream Clients in Global Market
Table 87. PET Radiopharmaceuticals Distributors and Sales Agents in Global Market
List of Figures
Figure 1. PET Radiopharmaceuticals Segment by Type
Figure 2. PET Radiopharmaceuticals Segment by Application
Figure 3. Global PET Radiopharmaceuticals Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global PET Radiopharmaceuticals Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global PET Radiopharmaceuticals Revenue, 2017-2028 (US$, Mn)
Figure 7. PET Radiopharmaceuticals Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by PET Radiopharmaceuticals Revenue in 2021
Figure 9. By Type - Global PET Radiopharmaceuticals Sales Market Share, 2017-2028
Figure 10. By Type - Global PET Radiopharmaceuticals Revenue Market Share, 2017-2028
Figure 11. By Type - Global PET Radiopharmaceuticals Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global PET Radiopharmaceuticals Sales Market Share, 2017-2028
Figure 13. By Application - Global PET Radiopharmaceuticals Revenue Market Share, 2017-2028
Figure 14. By Application - Global PET Radiopharmaceuticals Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global PET Radiopharmaceuticals Sales Market Share, 2017-2028
Figure 16. By Region - Global PET Radiopharmaceuticals Revenue Market Share, 2017-2028
Figure 17. By Country - North America PET Radiopharmaceuticals Revenue Market Share, 2017-2028
Figure 18. By Country - North America PET Radiopharmaceuticals Sales Market Share, 2017-2028
Figure 19. US PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 20. Canada PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe PET Radiopharmaceuticals Revenue Market Share, 2017-2028
Figure 23. By Country - Europe PET Radiopharmaceuticals Sales Market Share, 2017-2028
Figure 24. Germany PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 25. France PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 27. Italy PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 28. Russia PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia PET Radiopharmaceuticals Revenue Market Share, 2017-2028
Figure 32. By Region - Asia PET Radiopharmaceuticals Sales Market Share, 2017-2028
Figure 33. China PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 34. Japan PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 37. India PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America PET Radiopharmaceuticals Revenue Market Share, 2017-2028
Figure 39. By Country - South America PET Radiopharmaceuticals Sales Market Share, 2017-2028
Figure 40. Brazil PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa PET Radiopharmaceuticals Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa PET Radiopharmaceuticals Sales Market Share, 2017-2028
Figure 44. Turkey PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 45. Israel PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 47. UAE PET Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 48. Global PET Radiopharmaceuticals Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production PET Radiopharmaceuticals by Region, 2021 VS 2028
Figure 50. PET Radiopharmaceuticals Industry Value Chain
Figure 51. Marketing Channels
